NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

I've had companies that conduct trials in partnership with big pharma under cost sharing arrangements and, after positive results, are in a stronger position to negotiate better terms.

Thats all good and great for biotech with a strong balance sheet and positive equity but that is not NWBO

If you think that NWBO is in any position to share the cost of hundreds of $millions costing combo trialS over the next few years then I suggest you check the last balance sheet from their last 10Q again. Its absurd if Linda Powers would, in the cash position they are in now, agree NWBO to such huge cash commitments. If NWBO has not agreed to a strong upfront payment for the combo trials then not only are they terrible negotiators but then they have put NWBO in a dangerous position as well to have committed and agreed to payments they are most likely not able to afford.

Therefore I find it incredibly unlikely that Linda Powers would do such a stupid and unnecessary thing and agree to combo trials without strong upfront payments.

Or do you think Nektar made a stupid move when they were paid $1.85 billion upfront by Bristol-Myers Squibb?

https://news.bms.com/news/partnering/2018/Bristol-Myers-Squibb-and-Nektar-Therapeutics-Announce-Global-Development--Commercialization-Collaboration-for-Nektars-CD122-biased-Agonist-NKTR-214/default.aspx